SciELO - Scientific Electronic Library Online

 
vol.40 issue3Validation of an instrument to measure satisfaction of kidney patients treated by telemedicine during the COVID-19 pandemicEctopic pregnancy in cesarean scar: case report author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Acta Médica Peruana

On-line version ISSN 1728-5917

Abstract

JIMENEZ-CASTILLO, Gilberto A.; MARTINEZ-BRAVO, Luis E.  and  ANAYA-ESCAMILLA, Antonio. Diabetic Neuropathy: A narrative review of pathophysiology, diagnosis, and treatment. Acta méd. Peru [online]. 2023, vol.40, n.3, pp.243-251.  Epub Oct 22, 2023. ISSN 1728-5917.  http://dx.doi.org/10.35663/amp.2023.403.2731.

Diabetic neuropathy occurs in up to 60% of diabetic patients. Diabetic peripheral neuropathy is the most common cause of neuropathy in the world. The pathophysiology of diabetic neuropathy involves peripheral nerve damage due to the accumulation of toxic products derived from hyperglycemia. The central nervous system is subsequently involved through sensitization, decreased function of the inhibitory system, and increased excitability of the facilitative system. The most common symptoms manifest symmetrically, affecting small and large sensory fibers, although atypical forms of presentation have been found. Confirmatory diagnostic tests are reserved for diagnostic doubt, atypical symptoms, or research. The consensus regarding treatment is the prescription of gabapentinoids, tricyclic antidepressants, and serotonin and norepinephrine reuptake inhibitors. These three families are considered the first line.

Keywords : Diabetic Neuropathies; Neuralgia; Diabetes Mellitus.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )